Geen informatie
< 2 jaar: Off-label
≥ 2 jaar: On-label
Per ml oordr.:
Hydrocortison 10 mg, Neomycinesulfaat 5 mg, Polymyxine-B-sulfaat 10000 IE, 10 ml
| Otorrhoea in middle ear inflammation with the presence of perforation or tube |
|---|
|
GFR ≥10 ml/min/1.73m2: Dose adjustment not required.
GFR <10 ml/min/1.73m2: A general recommendation on dose adjustment cannot be provided.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Stekend en branderig gevoel bij geperforeerd trommelvlies. Overgevoeligheidsverschijnselen. Neomycine kan frequent en polymyxine in mindere mate sensibilisatie veroorzaken. Ototoxiciteit (bij systemische resorptie). Langdurig gebruik van corticosteroïden in het oor kan leiden tot atrofie en perforatie van het trommelvlies.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Beschadiging/perforatie van het trommelvlies of vermoeden hiervan. Aandoeningen, primair veroorzaakt door een bacterie, virus, schimmel, gist of parasiet. Ulcereuze aandoeningen, wonden. Neonaten. Overgevoeligheid voor aminoglycosiden en polymyxinen.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
No information available on specific warnings and precautions in children.
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Corticosteroids and antiinfectives in combination | ||
|---|---|---|
| S02CA03 | ||
| S02CA03 | ||
| S02CA06 | ||
| S02CA07 | ||
| S02CA07 | ||
| S02CA03 | ||
| S02CA04 | ||